Page last updated: 2024-08-25

chitosan and Pneumonia, Pneumococcal

chitosan has been researched along with Pneumonia, Pneumococcal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chhibber, S; Dube, T; Gondil, VS; Harjai, K; Panda, JJ; Yennamalli, RM	1

Other Studies

1 other study(ies) available for chitosan and Pneumonia, Pneumococcal

Article	Year
Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections. International journal of pharmaceutics, 2020, Jan-05, Volume: 573 Topics: A549 Cells; Administration, Intranasal; Animals; Bacteriophages; Biological Availability; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Drug Liberation; Endopeptidases; Feasibility Studies; Half-Life; Humans; Male; Materials Testing; Mice; Molecular Docking Simulation; Nanoparticles; Pneumonia, Pneumococcal; Recombinant Proteins; Streptococcus pneumoniae; Viral Proteins	2020

Article

Year

Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections.

International journal of pharmaceutics, 2020, Jan-05, Volume: 573

Topics: A549 Cells; Administration, Intranasal; Animals; Bacteriophages; Biological Availability; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Drug Liberation; Endopeptidases; Feasibility Studies; Half-Life; Humans; Male; Materials Testing; Mice; Molecular Docking Simulation; Nanoparticles; Pneumonia, Pneumococcal; Recombinant Proteins; Streptococcus pneumoniae; Viral Proteins

2020